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ABSTRACT
Alzheimer’s Disease (AD), already the most common cause of dementia, is a rapidly
escalating worldwide health concern thanks to increasing life expectancies and aging
populations. This work explores the utility of using magnitude (ERSP), phase angle
(ITPC), and cross-frequency coupling (PAC) indices derived from electroencephalogram
(EEG) recording using spectral decomposition as unique biomarkers of AD and
amnestic mild cognitive impairment (aMCI), respectively. The experimental protocol
was a visual oddball discrimination task conducted during a brief (approximately 20
minute) recording session. Participants were 60 older adults from an outpatient
memory clinic diagnosed with either aMCI (n=29; M=73.0; SD=9.32) or AD (n=31;
M=78.29; SD=8.28) according to NIA-AA criteria. Results indicate that ITPC values
differ significantly between AD and MCI groups. Findings contribute to a growing body
of literature seeking to document illness-related abnormalities in time-frequency EEG
signatures that may serve as reliable indicators of the pathophysiological processes
underlying the cognitive deficits observed in AD and aMCI-afflicted populations.
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Dissociating Alzheimer’s Disease from Amnestic Mild Cognitive Impairment Using TimeFrequency Based EEG Neurometrics
Alzheimer’s Disease (AD) is a progressive, incurable neurodegenerative disorder
characterized chiefly by memory impairment early in the course of the disease (Albert &
Moss, 1999), eventually giving way to a host of behavioral and cognitive deficits which
prevent those afflicted from autonomously performing most activities of daily living
(ADLs; McKhann et al., 2011). Already the most common form of dementia (Buckner,
2004; Jiang, Yu, Tian, & Tan, 2013), the number of those suffering from AD is projected
to reach epidemic proportions in the coming decades (Brookmeyer, Johnson, ZieglerGraham, & Arrighi, 2007) as the proportion of individuals aged 65 and older constituting
the worldwide population inexorably climbs. The development of biomarkers - objective
measures of a pathogenic process that can be used to gauge risk for or track the
progression of a disease (Hampel et al., 2010) – of AD has enabled the identification of
at-risk individuals prior to the onset of overt cognitive and behavioral symptoms in
research settings, yet still only around one-quarter of those afflicted with AD are
receiving a diagnosis (Prince, 2016). No biomarker or set of biomarkers has/have yet
been sufficiently validated for clinical application, and currently accepted biomarkers for
research study inclusion are too costly, invasive, and/or require too much specialized
equipment to be economically or ethically feasible on a large scale (Scally, Calderon,
Anghinah, & Parra, 2016). Additionally, current AD biomarker research efforts largely
fail to investigate potential measures that may aid clinicians in distinguishing between
mild cognitive impairment (MCI) and AD, focusing on the distinction between age
matched control and AD-afflicted populations. As MCI often presages the eventual
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development of AD, objective measures to aid clinicians in distinguishing between MCI
and AD and that could serve, post-diagnosis, as indices of the efficacy and, eventually,
the effectiveness of treatment interventions would be an enormous medical and societal
benefit.
The current study tests for concordance between established cognitive and
physiological indicators of AD and MCI and measures of the magnitude, phase, and
phase-amplitude coupling (PAC) of frequencies derived from electroencephalogram
(EEG) recording using spectral decomposition. Participants performed a visual oddball
discrimination task (Hillyard & Kutas, 1983), in which occasional, relevant ‘target’ stimuli
must be detected in a train of frequent, irrelevant ‘non-target’ stimuli. Note that, despite
advances in neuroimaging and genetic risk profiling, definitive confirmation of an AD
diagnosis can still only be made via post-mortem neuropathological examination to
confirm the presence of neurofibrillary tangles (NFTs) and senile plaques (Dauwels,
Vialatte, & Cichocki, 2010; Hyman et al., 2012); however, hereafter this document will
refer to probable but unconfirmed AD simply as AD. Additionally, all references made to
AD throughout this paper – unless explicitly noted – refer to late-onset (age 65 or older)
AD. Early-onset AD, which constitutes only around 1 - 5.5% (Sassi et al., 2014; Zhu et
al., 2015) of the total patient population, exhibits a pattern and time course of cognitive
impairment distinct from the far more common, late-onset AD cases (Smits et al., 2012).
As EEG diagnostic indicators similarly show a differential pattern of abnormalities in
early, as compared to late, onset AD (De Waal et al., 2011), generalizing findings from
the current sample population, which does not contain any individuals diagnosed as
early-onset, would be unwarranted.
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The most recently suggested diagnostic criteria from the National Institute on
Aging/Alzheimer’s Association (NIA-AA) defines three distinct stages of AD: Preclinical
AD, mild cognitive impairment (MCI) due to AD, and probable AD (Albert et al., 2011;
Jack et al., 2011; McKhann et al., 2011; Sperling et al., 2011). This tripartite
conceptualization of AD formalizes the evolving understanding of the disease as a
gradient of progressive neural degeneration, not simply an all-or-none phenomenon.
Preclinical AD individuals are asymptomatic, presenting only biomarker-based evidence
of neurological disorder (Sperling et al., 2011). Observable cognitive and behavioral
impairments characterize the MCI phase of AD, with this stage of the disease
representing a transitional state between normal aging and AD. Amongst MCI patients,
approximately 10–25% of individuals transition to AD within a given one-year period
(Petersen, 2000; Petersen et al., 1999; Petersen et al., 2001). Crucially, clinical
symptoms brought on by AD pathology often do not manifest until years after the onset
of neurodegeneration (Braak, Braak, & Bohl, 1993; Sperling et al., 2011). By the onset
of clinically diagnosable AD, significant and irreversible tissue damage is likely to have
occurred, accompanied by detectable atrophy of brain mass compared to both MCI and
healthy controls (Hua et al., 2008). Current clinical trials of preventative drugs likely
begin too far along in the timeline of AD, when significant and irreparable tissue damage
is already likely to have occurred (Godyń, Jończyk, Panek, & Malawska, 2016). As
noted by Cummings and colleagues (2007), both treatment and preventative therapies
aimed at altering the pathogenesis of the disease are more likely to be effective if begun
at pre-dementia stages.
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Given the progressive nature of AD and the temporal separation between the
beginning of neural degeneration and the onset of overt behavioral deficits (Price &
Morris, 1999), there is widespread agreement on the pressing need for reliable,
sensitive, and specific biomarkers of AD and MCI, with both the International Working
Group (IWG; Dubois et al., 2007, 2010) and the National Institute on Aging/Alzheimer’s
Association (NIA-AA; Albert et al., 2011; Jack et al., 2011; McKhann et al., 2011;
Sperling et al., 2011) recommending continued development and verification of such
measures. Current research recommendations center on using multi-modal biomarkers
including genetic, structural neuroimaging, and functional neuroimaging (Dubois et al.,
2007; McKhann et al., 2011), while largely ignoring neurophysiological methods such as
EEG. Some workgroups (e.g. Jackson & Snyder, 2008; Yener & Başar, 2013) have
pointed out that EEG possesses many desirable features that recommend its inclusion
in the search for optimal sets of biomarkers of AD and MCI.

As noted by Ashford,

Rosen, Adamson, and Bayley (2011):
In many ways EEG offers an ideal method for assessing brain function. Its
exquisite temporal resolution can track brain activity in the millisecond time
domain characteristic of neuronal activity in the cortical substrate. It is entirely
noninvasive and employs no ionizing radiation. It records both excitatory and
inhibitory signals directly rather than secondary hemodynamic processes. It also
is inexpensive (p. 375).
Such a feature set contrasts, in many respects, with current biomarkers commonly used
as inclusion criteria for research studies.
4

Biomarkers of Alzheimer’s Disease
Since Alois Alzheimer first documented their presence during autopsy of a
patient suffering from the disease that would later bear his name, intracellular plaques
and extracellular NFTs have become the telltale, physically defining features of AD
(Golde, Eckman, & Younkin, 2000; Mattson, 2004; Walsh and Selkoe, 2004). It has
long been suggested that aggregation of amyloid beta (Aβ) is the initiating factor in the
pathogenic chain of AD (Hardy & Selkoe, 2002), with the popular (although not
uncontroversial; see, e.g., Herrup, 2015) amyloid cascade hypothesis positing that Aβ
accumulation and plaque formation drives the formation of NFTs of
hyperphosphorylated tau protein that correlate strongly with the progressive neuronal
dysfunction observed in AD (reviewed in Holtzman, Morris, & Goate, 2011).
Imaging the toxic Aβ peptides that comprise the extracellular plaques
characteristic of AD using positron emission tomography (PET) has enabled the
identification of Aβ deposits far preceding the commencement of overt cognitive decline,
with a recent study (Rodriguez-Vieitez et al., 2016) showing fibrillar Aβ plaque
accumulation characteristic of AD appearing as much as 17 years before the expected
onset of overt clinical symptoms. Aβ plaque accumulation far pre-dating the onset of
clinical AD symptoms has become well established (e.g. Bateman et al., 2012; Mintun
et al., 2006; Sperling et al., 2011), but the fact that non-demented elderly subjects often
display significant Aβ plaque burden (Quigley et al., 2011) suggests that such a
measure alone cannot provide an accurate early diagnosis that is unique to AD.
Additionally, PET imaging is not widely available, is quite expensive, and The National
5

Research Council (NRC, 2007) reports that demand for the radionucleotides used in
PET scans is likely to far outstrip the available supply in the coming decades.
Measuring, via cerebrospinal fluid (CSF) draw, levels of Aβ along with levels of
phosphorylated tau proteins (P-tau and T-tau) that form intracellular NFTs is an invasive
procedure requiring lumbar puncture with a catheter. Both Aβ and tau levels tend to
remain relatively stable over time (Blennow, Mattsson, Schöll, Hansson, & Zetterberg,
2015; Blennow et al., 2007), which is a desirable quality for gauging the efficacy of
treatment interventions but suggests that these measures are not ideally suited to
gauge disease progression in de novo individuals.
For nearly two decades, multiple genes have been associated with increased AD
risk (Karch, Cruchaga, & Goate, 2014). Certain mutations in amyloid precursor proteins
(APPs) presenilin-1 (PSEN 1) and presenilin-2 (PSEN 2) are known to cause earlyonset AD (reviewed in Guerreiro, Gustafson, & Hardy, 2012), and a specific isoform of
Apolipoprotein E (APOE), APOEε4, indicates a substantially increased risk for both
early- and late-onset AD (reviewed in Guerreiro, Gustafson, & Hardy, 2012). However,
as previously noted, early-onset AD comprises only a small fraction of the total AD
population, and furthermore, only 50% of individuals with AD carry an APOEε4 allele
(Karch, Cruchaga, & Goate, 2014). As genetic composition is fixed throughout the
lifetime, genomic biomarkers appear better suited to identifying at-risk individuals than
to either detecting the actual presence or gauging the progression of AD-related
pathology.
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Structural magnetic resonance imaging (MRI) studies reliably find pronounced
atrophy of the hippocampus and surrounding areas of temporal cortex in patients with
AD (e.g., Jack, Petersen, O'Brien, & Tangalos, 1992; Killiany & Albert, 1993; reviewed
in Jack & Petersen, 2000), as well as hippocampal shape deformation (Csernansky et
al., 2000). Cell loss in areas of the medial temporal cortex including the hippocampus
likely contributes significantly to impaired memory performance in individuals with AD
(reviewed in Albert, 1997), as the medial temporal region is important to both working
(Ranganath, 2006) and long-term (Squire, 1992) memory. Temporal lobe atrophy
revealed through structural MRI also appears to be a viable diagnostic tool with which to
gauge the progression of MCI and AD, as temporal lobe volume decreases in proportion
to disease severity (Jack et al., 2011) and has been able to predict the conversion from
MCI to AD (DeCarli et al., 2007). On the downside, MRI imaging is expensive, with
costs generally spanning from several hundred to several thousand dollars per session,
and the technology requires substantial investment on the part of a research or medical
facility both to purchase an MRI scanner and to properly shield surrounding areas from
the extreme magnetic forces employed by this type of imaging.
Despite its long history (Berger, 1929), low costs of operation, and non-invasive
nature, EEG has to date failed to receive widespread clinical acceptance in the context
of AD and MCI diagnosis and/or progression monitoring. Yet, among all potential
biomarkers of AD so far discussed, EEG alone possesses sufficient temporal resolution
to measure synaptic activity in real-time (Cook & Leuchter, 1996). As AD has been
conceptualized as (among many things) primarily a disorder of synaptic plasticity (Klein,
2006; Selkoe, 2002; Walsh et al., 2002), a measure sensitive to changes in synaptic
7

performance could provide an important, unique metric by which to gauge progression
of the underlying pathogenic processes of AD. Altered synaptic plasticity far preceding
the appearance of Aβ containing plaques and brain atrophy in animal models (Hsia et
al., 1999; Lesné et al., 2006; Rowan, Klyubin, Cullen, & Anwyl, 2003) further supports
the notion that EEG-derived measures could be even more sensitive to early functional
alterations occurring in AD than is volumetric assessment of temporal lobe atrophy via
structural MRI (Olichney, Yang, Taylor, & Kutas, 2011). However, some studies
indicate that the accuracy with which EEG derived measures can correctly identify AD
patients from healthy controls is both poor and highly variable (Stam et al., 1996), and
large inter-individual variation in these readings often prevents detection of AD at the
individual level (Yener & Başar, 2013). Decomposing the observed EEG signal into its
constituent frequency bands and examining stimulus responses within these individual
bands may provide a means of improving the accuracy and specificity with which AD
and MCI can be detected and distinguished, as these narrow band frequency responses
may better reflect specific aspects of cognitive function (Başar, 2004).
Time-frequency EEG measures of Brain Oscillations
As a sweeping generalization, the rhythmically fluctuating, periodic and/or quasiperiodic signal observed in EEG recordings can be said to reflect the summated
dendritic post-synaptic potentials of millions to billions of – primarily – cortical pyramidal
neurons (Buzsáki, Anastassiou, & Koch, 2012; da Silva, 2013). The observed
magnitude of the electrical fields caused by transmembrane potentials created as
charged ions flow into and out of neurons constitute what Buzsáki (2002) terms the
8

current generator portion of the signal. Other mechanisms - or rhythm generators
(Buzsáki, 2002) - give rise to the timing and frequency of the signal and are held to be
especially important in coordinating firing patterns in neuronal networks (Singer, 1999).
Inhibitory interneurons play a particularly prominent role in timing rhythmic activity in the
brain (Mann & Paulsen, 2007), as their dense interconnections within local networks
allow them to influence numerous neurons, creating cyclical fluctuations between high
and low-probability spiking behavior (Traub et al., 2002). Such alternation between
increased and decreased action potential probability entrains principle neurons into
synchronized firing patterns (Mann & Paulsen, 2007) typically described as neural
oscillations, or – more colloquially – brain rhythms.
Once widely regarded as mere epiphenomena, oscillations are increasingly
viewed as playing a functionally meaningful role in cognitive processes (e.g. Fries,
Reynolds, Rorie, & Desimone, 2001; Ward, 2003). The timing function provided by
oscillations, as entrained neurons alternate between periods of excitation and inhibition,
opens windows of opportunity within which communication between neurons is
maximally effective (Fries, 2005). Notably, such facilitation of communication through
temporal coordination can be achieved even in lieu of an increase in overall spiking
behavior, by grouping spikes into compressed time windows particularly effective at
activating downstream neurons (Azouz & Gray, 2000; Salinas & Sejnowski, 2001).
Oscillatory activity can be subdivided into the actions of true oscillators – neurons
capable of self-sustained rhythmic firing independent of synaptic input – versus that of
resonators, or neurons that are preferentially induced to fire rhythmically in response to
oscillatory synaptic input at specific frequencies (Llinas, 1988). Neurons in different
9

brain regions can exhibit resonant frequency preference towards oscillations of multiple
frequencies (Jacobs, Kahana, Ekstrom, & Fried, 2007) with neocortical pyramidal
neurons, for example, displaying both low and high frequency resonance (Hutcheon &
Yarom, 2000). However, as distinguishing between true oscillators and resonators
involves features detectable at the single-cell level of observation (Llinas, 1988), such a
fine-grained distinction will not be made in the present work and all references to
oscillations or oscillatory activity made herein may be more accurately taken to mean
the activity of neuronal populations comprising true oscillators and/or resonators.
Filtering continuous EEG data into its constituent sinusoidal components reveals
the underlying frequency content of the signal, which can then be displayed as a
distribution of signal power over discrete frequency bands (see Figure 1). Not all
rhythmic brain activity reveled by EEG is oscillatory in nature (Miller, Honey, Hermes,
Rao, & Ojemann, 2014), with the croquet-hoop shaped positive deflections of murhythms (~9-11 Hz) representing one exception (Gross, 2014), as they fail to exhibit a
clear spectral peak. Neural oscillatory activity is, however, the most prominent feature
of EEG (Cohen, 2017), and patterns and changes in these narrow-band signals has
recently begun garnering significant attention in studies of cognitive dynamics in both
healthy and clinical populations. Oscillatory activity as fast as 600 Hz has been
identified in human EEG (Curio, 1999; Curio et al., 1994), but the frequency bands most
often studied are delta (>1 – 4 Hz), theta (4 – 8 Hz), alpha (8 – 12 Hz), beta (12 – 20
Hz) and gamma (20 – 80 Hz), which have been termed the natural frequencies of the
brain (Başar, Başar-Eroglu, Karakaş, & Schürmann, 2001). Any signal, including
indicators of brain oscillations, can be fully described by its spectral properties,
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consisting of the amplitude (or power, the square of the amplitude), frequency, and
phase of the observed signal. Broadly: Frequency can be taken as an indicator of the
speed, phase activity as a measure of the timing, and power as a measure of the
strength of the underlying neuronal activity (Cohen, 2014). Importantly, these three
signal properties provide largely independent information, save for a reciprocal
relationship between amplitude and frequency, with amplitude decreasing along with
increasing signal frequency in a roughly 1/f (amplitude = 1/frequency) manner
(Freeman, Rogers, Holmes, & Silbergeld, 2000).
As EEG observed at the scalp represents a summed total of the activity of large
neuronal populations (Başar, 1980; Steriade, Gloor, Llinas, da Silva, & Mesulam, 1990),
amplitude increases can be caused by either more neurons with the same degree of
inter-neuronal synchrony or the same number of neurons exhibiting a higher degree of
inter-neuronal synchrony (Herrmann & Demiralp, 2005). Thus, including phase
information in the analysis of cognitive processing gives a more complete picture of the
underlying temporal dynamics of the involved oscillatory processes “stripped” of the
influence of amplitude (Cohen, 2014; Roach & Mathalon, 2008). Oscillatory activity in
the brain can exhibit three types of synchrony: Inter-neuronal, inter-electrode, and/or
inter-trial (Herrmann & Demiralp, 2005). Event-related phase consistency across trials
at a single electrode is especially important when studying event-related oscillations
(EROs; Herrmann & Demiralp, 2005), and will be the only measure of phase
synchronization discussed in this paper. As a definitional note, inter-trial phase
clustering (ITPC) - also variously referred to as phase-locking value, phase-locking
factor, phase resetting, phase coherence, inter-trial phase coherence, and/or cross-trial
11

phase coherence (Cohen, 2014) - will be the term used to describe this type of neuronal
synchronization throughout the present work. By convention, coherence usually
denotes phase synchronization between two separate recording sites (electrodes)
(Andrew & Pfurtscheller, 1996), while locking describes synchronization at a single-site
(electrode) across trials (Roach & Mathalon, 2008): However, the use of the term ITPC
appears to be becoming somewhat standard practice in the EEG literature of late. The
term synchronization itself has manifold uses in the extant literature: Synchronization
can generally describe high amplitude, low frequency activity in the EEG (Steriade,
Gloor, Llinas, Da Silva, & Mesulam, 1990); synchronization can be a measure of the
relation between the temporal structure (rhythm) of signals regardless of signal
amplitude (Varela, Lachaux, Rodriguez, & Martinerie, 2001); and event related
synchronization (ERS) is sometimes used to denote an increase in power from baseline
within a given frequency band (Pfurtscheller, 1992).
EEG as a Potential Biomarker of AD
The earliest and most numerous studies (e.g. Başar & Güntekin, 2008; Brenner
et al., 1986; Coben, Danziger, & Berg, 1983; Duffy, Albert, & McAnulty, 1984)
investigating potential EEG indices of AD utilized mainly resting state (spontaneous)
EEG, in which participants sit motionless for several minutes while having brain activity
recorded. These studies reliably show a pronounced slowing of the EEG signal in
individuals with AD (Czigler et al. 2008; Dauwels, Vialatte, & Cichocki, 2010; Moretti et
al. 2009; reviewed in Jackson & Snyder, 2008), with a higher proportion of signal power
manifesting in lower frequency bands and continued slowing that progresses along with
12

advancing cognitive impairment (Bennys, Rondouin, Vergnes, & Touchon, 2001; Jeong,
2004; Schreiter-Gasser, Gasser, & Ziegler,1994). While the resting state testing
protocol has the advantage of being undemanding for participants and has
demonstrated impressive discriminating performance in some studies, results involving
this method are mixed. For example: Lehmann and colleagues (2007) reported resting
state measures that differentiated mild AD subjects from healthy controls with 85%
sensitivity and 78% specificity, while a meta-analysis of resting state studies (Jelic &
Kowalski, 2009) showed that classification accuracies between AD and controls ranged
between 2.3% and 38.5%, with diagnostic odds ratios (a ratio of the odds of the test
being positive if an individual has a disease to the odds of the test being positive if that
individual does not have the disease) between 7 and 219. Such variability may be
partially attributable to the fact that, in the context of a never silent brain, “the alleged
‘resting state’ is ill defined and difficult to control” (Gross, 2014, p.59).
As the testing protocol typically lacks any type of cognitive or sensory stimulation,
resting state recordings may not be sensitive enough to produce significant group
differences in spectral EEG metrics (Günther et al., 1993). In contrast to recording
spontaneous or resting state activity, event-related (ER) paradigms measure the
electrical response of the brain to a stimulus, typically to an infrequently presented
target stimulus nested within a sequence of similar but more frequent stimuli in an
oddball paradigm (Başar, Başar-Eroğlu, Güntekin, & Yener, 2013). Consequently, it
has been suggested that ER responses can provide a more accurate evaluation of AD
(Polich & Herbst, 2000). Detection of oddball stimuli involves both sensory mechanisms
and cognitive processes including attention, perception, learning, and working memory
13

(Halgren, Boujon, Clarke, Wang, & Chauvel, 2002; Klimesch et al., 2006; Rektor et al.,
2004). This set of cognitive mechanisms is notable in that it encompasses many of the
executive functions most affected by AD (Collette, Van der Linden, & Salmon, 1999;
Lafleche & Albert, 1995). Intuitively, directly probing an impaired functional process
such as memory appears much more likely to reveal specific, rather than general,
patterns of neural dysfunction corresponding to the cognitive deficits seen in AD and
MCI patient populations.
Event-related EEG experimental protocols elicit both induced and evoked
oscillatory responses: Induced responses – also called event-related spectral
perturbations (ERSPs; Makeig, 1993) - follow, but are not phase-locked to, sensory
stimuli (Engel, König, Kreiter, Schillen, & Singer, 1992), while earlier occurring evoked
oscillatory responses consistently and precisely phase synchronize to a stimulus
(Herrmann & Demiralp, 2005; Tallon-Baudry & Bertrand, 1999). Evoked EEG activity
emerges automatically in response to audio, visual, or somatosensory stimuli of
sufficient magnitude (Herrmann, Grigutsch, & Busch, 2005) and typically occurs within
the first 200 ms following stimulus onset (Roach & Mathalon, 2008). Accordingly, eventrelated activity revealed by spectral decomposition of the EEG signal can be further
sub-divided into obligatory responses elicited by simple sensory stimuli (sensory-related
oscillations; SROs) and event-related oscillations (EROs) that reflect higher cognitive
processing (Yener & Başar, 2010). Evoked and induced (ERSP) responses are also more descriptively - referred to as phase locked and non-phase locked activity,
respectively. Activity that is both time and phase locked shows up in the familiar eventrelated potential (ERP), while the time-domain averaging process involved in creating
14

ERPs cancels out all activity that is not tightly time and phase locked to stimulus onset
(Makeig, 1993). To obtain a picture of non-phase locked activity, the EEG signal is first
transformed into the frequency domain, using methods such as Morlet wavelet
convolution or bandpass filtering, prior to averaging across trials (Tallon-Baudry &
Bertrand, 1999). EROs enable examination of parallel processing activity in the brain
by revealing associations between simultaneously occurring processes taking place at
different frequencies (Lisman & Buzsáki, 2008), yielding a more detailed picture of
event-related brain activity relative to ERPs (Roach & Mathalon, 2008). Thus, it has
been suggested that examining the full spectra of EEG activity generated in response to
cognitive tasks affords the clearest and most comprehensive assessment of damaged
cognitive networks in cases such as AD (Başar, Başar-Eroğlu, Güntekin, & Yener,
2013), a level of detail highly desirable when attempting to make a fine-grained
distinction such as that between the conditions of MCI and AD. Supporting the
enhanced diagnostic potential of time-frequency based measures, Ford and colleagues
(2008) found both phase and power measures induced by an oddball task to be more
sensitive to schizophrenia than the P300 component of the ERP.
As empirical studies associating event-related oscillatory activity with cognitive
functions accumulate, two frequency bands particularly implicated in the study of
memory processes and psychopathological impairment of memory are theta (4-8 Hz)
and gamma (30-80 Hz), along with – increasingly – studies of their association.
Theta. Of all EEG frequency bands, theta has been the most consistently found to
relate to human memory performance (Klimesch et al., 2005), especially during the
15

active maintenance of items in working memory (WM; Sauseng, Klimesch, Schabus, &
Doppelmayr, 2005). While the majority of theta activity recorded at the scalp is likely to
originate from cortical sources, as areas such as cingulate and perirhinal cortices have
been found to be the main drivers of amplitude fluctuations in extracellular recordings
(Buzsáki, 2002), depth electrode recordings in animals indicate that theta oscillations
are largest in amplitude and most regular in frequency in the hippocampus (Buzsáki,
2002). Theta activity originating in the hippocampus is thought to help time interactions
between prefrontal cortex and hippocampus during memory-guided action selection
(Hasselmo, 2005), and the theta and delta frequency ranges are the primary
constituents of the P300 ERP component (Başar-Eroglu, Başar, Demiralp, &
Schürmann, 1992) commonly linked to functions such as memory matching, attention,
and decision-making. Importantly, alterations in delta and theta activity are also
consistently found to be abnormal in studies of AD pathology utilizing the oddball
paradigm (Caravaglios, Costanzo, Palermo, & Muscoso, 2008; Yener, Güntekin, &
Başar, 2008).
While consistently linked, the relationship between theta and memory
performance appears to be highly nuanced and at least partially non-linear (Klimesch,
1999). Theta power is increased during memory encoding (Başar, Başar-Eroğlu,
Karakaş, & Schürmann, 2000; Klimesch, 1999; Paré, Collins, & Pelletier, 2002) and
increases along with the number of items concurrently maintained in working memory
(Jensen & Tesche, 2002). However, findings by Klimesch (1999) indicate differential
patterns of theta activity for good versus poorly performing subjects in a cognitive task:
Good performers tend to exhibit lower pre-stimulus baseline (tonic) theta band power
16

along with highly increased event related theta power relative to baseline, while these
values are reversed in poor performers. In addition to power, consistent theta band
phase locking may contribute meaningfully to successful episodic memory encoding, as
precise timing of neuronal spiking with respect to ongoing theta may predict successful
encoding of memories even in the absence of a net increase in hippocampal firing rate
(Rutishauser, Ross, Mamelak, & Schuman, 2010). Theta is also held to represent
different aspects of episodic memory retrieval depending upon the time window in
question, with early activity (~100-400 ms post-stimulus) reflecting either encoding of
new information or recall of old information, and late activity (after ~500 ms) indicating
evaluation of an episodic trace (Klimesch et al., 2005). Significant increases in theta
power during the encoding phase corresponds to items that are later successfully
recalled (Klimesch, Doppelmayr, Pachinger, & Ripper, 1997; Klimesch, Doppelmayr,
Russegger, & Pachinger, 1996), while late increases in theta reflect the increasing
cognitive demands associated with evaluating weaker memory traces (Klimsche et al.,
2005). The time course of theta activity has also been shown to differentiate between
the conscious states of knowing versus remembering items (Klimesch et al., 2001).
Klimesch and colleagues (2001), in line with behavioral results indicating that familiarity
judgements are made more rapidly than are judgements requiring recall of specific
episodic information (Düzel, Yonelinas, Mangun, Heinze, & Tulving, 1997), found
familiar (known) words to elicit the largest theta increase in the early (200-375 ms) poststimulus period while explicitly remembering recently presented words coincided with
the largest increases in late-period (500-625 ms) theta power. In the oddball paradigm,
theta activity is prolonged for target as compared to standard stimuli (Başar-Eroglu,
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Başar, Demiralp, & Schürmann, 1992; Demiralp & Ademoglu, 2001; Yordanova &
Kolev, 1998).
Consistent with the differing pattern of theta power changes observed for good
versus bad memory performers amongst healthy subjects (Klimesch, 1999), Missonnier
and coworkers (2006) found progressive MCI cases to exhibit significantly lower eventrelated theta power over all electrode sites compared to stable MCI cases. At least two
studies (Hogan, Swanwick, Kaiser, Rowan, & Lawlor, 2003; Karrasch et al., 2006) have
failed to find the expected differences between AD patients and controls in the theta
range during memory recall. Karrasch and colleagues (2006) additionally found similar
theta power increases during encoding amongst controls and AD patients, while MCI
patients exhibited decreased event-related theta power. Such unexpected similarities
between controls and AD patients may indicate a non-linear relationship between theta
power and disease progression, may have been driven by temporal blurring of the lowfrequency signal due to the parameters of the wavelets used for spectral decomposition
(Karrasch et al., 2006), or might reflect the activation of different neuronal networks in
the controls and the AD patients (Karrasch et al., 2006). Another possibility is that
Acetylcholinesterase inhibitor (AChEI) medication status – not mentioned in either study
– could have produced theta-band profiles in medicated AD patients that resembled
those of healthy control subjects. Regarding this last possibility, Yenner and coworkers
(2007) found event-related theta phase locking in AChEl treated AD patients to be two
times higher than the values observed in untreated AD subjects, with medicated
individuals producing theta locking in left-frontal electrodes (F3) indistinguishable from
that of control subjects. Theta band activity appears highly malleable via
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pharmacological intervention, as even a single five mg administration of melatonin can
cause a significant increase in tonic theta band power (Cajochen et al., 1996).
As theta activity may arise from many different brain areas (Kahana, Sekuler,
Caplan, Kirschen, & Madsen, 1999) and the functional role played by theta may vary
with location (Ward, 2003), investigating specific topographical areas may prove
beneficial in elucidating the purposes of this frequency band in both normal and
pathological cognitive functioning. While primary sensory and motor areas are relatively
spared by AD pathogenesis (Braak, Braak, & Bohl, 1993), hyperexcitability of motor
(Ferreri et al., 2003) and visual sensory (Yener, Güntekin, Tülay, & Başar, 2009) cortical
areas within the theta band have been documented. Peak theta amplitude and phase
locking show the largest auditory and visual event-related decreases in AD in frontalcentral regions during cognitive tasks (Yener, Güntekin, Öniz, & Başar, 2007; reviewed
in Yener & Başar, 2013). Importantly, frontal sites also exhibit the most pronounced
increases in theta power during active maintenance of information in WM tasks
(Sauseng et al., 2004; Sauseng, Klimesch, Schabus, & Doppelmayr, 2005) in healthy
subjects.
Some of the increased theta activity consistently found in resting state studies of
AD is likely to be ‘slowed’ alpha activity (Klimesch, 1999; Steriade, Gloor, Llinas, da
Silva, & Mesulam, 1990). Such slowing is typically observed in normal, as well as
pathological, aging (Hartikainen, Soininen, Partanen, Helkala, & Riekkinen, 1992) and
may be related to a decreased rate of cerebral blood flow to cortical grey matter
(Stigsby, Jóhannesson, & Ingvar, 1981). Combined EEG and fMRI studies have shown
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that an inverse relationship exists between the blood-oxygen-level-dependent (BOLD)
signal and theta power (Michels et al., 2010; Scheeringa et al., 2009), and a negative
correlation between hippocampal volume and theta power has also been noted
(Grunwald, Hensel, Wolf, Weiss, & Gertz, 2007). Decreases in frequency may also
signal deteriorating functional connectivity within cognitive networks, as betterconnected feedback networks are assumed to produce higher frequency EEG readings
(Klimesch, 1999). Lower frequency brain activity corresponds to larger neuronal areas
contributing to the observed EEG signal, whereas higher frequencies indicate more
spatially localized activity (Singer, 1993). Thus, the slowing observed in AD – and, to a
lesser extent, regular aging – may also represent a mechanism by which the brain
achieves the well documented compensatory activation (e.g. Grady et al., 2003;
Sperling et al., 2003) patterns seen in neuroimaging studies of these groups.
Gamma. First observed in mammals following odorant stimulation of the olfactory bulb
of the hedgehog (Adrian, 1942), gamma responses are also elicited by stimuli of
sufficient magnitude arriving via all other sensory modalities. Following numerous early
investigations linking gamma band activity (GBA) to sensory processes, GBA is now
also associated with numerous higher order cognitive functions including selective
attention, short- and long-term memory, and problem solving (Jensen, Kaiser, &
Lachaux, 2007; reviewed in Rieder, Rahm, Williams, & Kaiser, 2011). Specifically,
increases in gamma power have been shown to correlate with successful memory
encoding (Long, Burke, & Kahana, 2014) and retrieval (Burke et al., 2014) in human
subjects. In line with the distinction between SROs (early, phase-locked) and EROs
(later, non-phase locked) previously mentioned, GBA can be roughly dichotomized into
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sensory- and cognitive-related gamma (Başar, Başar-Eroğlu, Karakaş, & Schürmann,
1999). Sensory triggered GBA originates in cortical areas responsible for early stage
processing of stimuli arriving via the corresponding sensory modality (Gruber, TrujilloBarreto, Giabbiconi, Valdés-Sosa, & Müller, 2006; Herrmann, Fründ, & Lenz, 2010;
Lachaux et al., 2000; Panteve et al., 1991), while cognitive-related GBA involves
widespread activation of both cortical and subcortical areas (Başar, Schürmann, BaşarEroglu, & Demiralp, 2001). Though there is evidence for overlapping functional
correlates (Debener, Herrmann, Kranczioch, Gembris, & Engel, 2003; Engel, Fries, &
Singer, 2001; Herrmann, Lenz, Junge, Busch, & Maess, 2004; Tiitinen et al., 1993) and
neural origins (Basar, 1980; Herrmann, 2001; Pantev et al., 1991) of early and late
GBA, the correspondence of early activity with sensory processes and later activity with
cognitive operations generally holds (Karakaş, Başar-Eroğlu, Özesmi, Kafadar, &
Erzengin, 2001).
Ascertaining the non-monolithic quality of the frequency band has done much to
clarify the “gamma puzzle” (Karakaş & Başar, 1998) concerning the precise functional
significance of GBA. Evidence suggests that the binding property of gamma oscillations
facilitated by their high speed activity serves to tie together multi-modal sensory signals
into singly experienced conscious percepts (Gray, 1994; Singer & Gray, 1995), while
GBA simultaneously functions as a basic building block of electrical communication in
the brain (Başar, Başar-Eroğlu, Karakaş, & Schürmann, 1999) as it performs many
higher order cognitive functions. Early and late GBA are not wholly independent
entities, however. Attention – perhaps the most often cited cognitive modulator of GBA
(e.g. Debener, Herrmann, Kranczioch, Gembris, & Engel, 2003; Müller, Gruber, & Keil,
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2000; Tiitinen et al., 1993) – has been shown to enhance early, sensory related GBA
(but see Karakaş & Başar, 1998). This “spotlighting” effect of attention (Norman, 1968;
Posner, 1980) thus provides evidence for top-down – in addition to bottom-up –
mechanisms of stimulus processing in the brain and suggests that both may be
subserved by GBA. The idea that all cognitive functions necessarily involve both
memory and perception (Hayek, 1952; Fuster, 1997; Goldman-Rakic, 1996) further
unites the two forms of GBA and underlies the match-and-utilization model (MUM) of
Hermann and coworkers (2004). The MUM holds that memory matching is the primary
cognitive functional correlate of GBA, underpinning all other gamma related cognitive
processes. Furthermore, according to the MUM GBA may serve as an index of the
strength of memory representations, as repeatedly associated objects strengthen
synaptic connections between associated neurons leading to stronger oscillations in the
gamma band for better remembered than for relatively novel stimuli.
The purported centrality of GBA to multiple higher cognitive functions has led to
numerous investigations into the role activity in this frequency band may play in
neuropsychiatric disorders such as AD. Given the strong evidential support for a
correlation between GBA and cognitive functions in general and memory specifically,
event-related testing paradigms focusing narrowly on this frequency band as an
indicator of clinical cognitive impairment have thus far yielded somewhat
underwhelming – and at times even contradictory – results. Several studies utilizing the
resting state protocol have found the expected reduction in GBA among AD patients
(König et al., 2005; Ribary et al., 1991; Stam et al., 2002), while others have failed to
find significant reductions (Babiloni et al., 2004), or even found increased gamma band
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power (van Deursen et al., 2008). Such discrepancies could be attributable to
significant individual differences in GBA (Karakaş, Başar-Eroğlu, Özesmi, Kafadar, &
Erzengin, 2001), methodological differences (van Deursen et al. 2008), and/or
frequency-band specific effects of medication. To this last point, the significant loss of
basal forebrain cholinergic neurons seen in AD (Coyle, Price, & Delong, 1983;
Whitehouse et al., 1982) might be expected to significantly impact GBA, as
acetylcholine has proven important to oscillatory synchronization in the gamma band
(Rodriguez, Kallenbach, Singer, & Munk, 2004). Acetylcholinesterase inhibitors
(AChEI), often prescribed for AD patients, have been shown to normalize the EEG of
AD patients by reducing the typical slowing pattern seen in the disease in both short(Adler & Brassen, 2001) and long-term (Jelic et al., 1998; Kogan et al, 2001) testing
windows. Reduced GBA observed in normal ageing (Böttger, Herrmann, & von Cramon,
2002) may be attributable to age-related decreases in dopamine D2 receptors
(Bäckman, Nyberg, Lindenberger, Li, & Farde, 2006; Li, Lindenberger, & Sikström,
2001), while the dopamine system is relatively spared by the pathogenic processes of
AD (Rossor & Iversen,1986). Such results suggest that reduced GBA observed in
normal ageing may be mediated by different neurotransmitters and neural networks
than is the decrease wrought by AD pathogenesis.
Theta-gamma coupling. A fundamental feature of oscillatory activity in the brain is the
modulation of localized, high speed activity by more widespread, low frequency rhythms
(Bragin et al., 1995; Chrobak & Buzsáki, 1998; Lakatos et al., 2005). Cross-frequency
coupling (CFC) - a statistical relationship between spectral elements of different
frequency bands - reveals complex, non-linear interactions between neuronal
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populations and can be observed both within and between brain regions (Onslow,
Bogacz, & Jones, 2011). While CFC has been detected between different frequency
band pairs and occurs in several brain regions including sensory (Lakatos et al., 2005)
and frontal cortex (Canolty et al., 2006), the most studied example of CFC involves
theta and gamma activity in the hippocampus (e.g. Axmacher et al., 2010; Buzsáki &
Draguhn, 2004; Mormann et al., 2005). Attempts at direct, 1:1 mapping of frequency
band activity in the brain onto particular behavioral and/or cognitive states has widely
met with failure, as evidenced by the ever-evolving notions regarding the behavioral
significance of theta band activity (Buzsáki, 2011) and the sensory versus cognitive
debate described as the gamma paradox (Karakaş & Başar, 1998). As “the coupling of
two or more oscillators could provide enhanced combinatorial opportunities for storing
complex temporal patterns and optimizing synaptic weights” (Buzsáki & Draguhn, 2004,
p.1929), investigations of CFC should greatly enhance the likelihood of elucidating
behavioral and cognitive correlates of frequency band activity. Interactions between
frequency bands revealed through CFC may, for instance, help explain the numerous
contradictory findings regarding changes in specific frequency band power during
successful memory encoding (reviewed in Hanslmayr & Staudigl, 2014).
As reviewed briefly in previous sections, activity in both theta and gamma bands
is modulated during memory tasks. Activity within each frequency band is thought to
both reflect and facilitate functional network connectivity, simultaneously allowing
specialized neuronal assemblies to encode information independently and interact
selectively according to situational demands (Fries, 2009; Varela, Lachaux, Rodriguez,
& Martinerie, 2001). However, it is now believed that interaction between – as well as
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within – individual frequency bands is required for the complexity required for higher
cognitive functioning (Le Van Quyen, 2011). GBA is highly localized, yet the results of
any local cortical computations must somehow be integrated globally (Buzsáki &
Draguhn, 2004). When contributions from higher association areas are required for the
execution of cognitive processes such as manipulating items in WM or consolidating
memories via the hippocampus, slower frequencies such as theta are needed to link
spatially localized GBA (Başar, Başar-Eroğlu, Karakaş, & Schürmann, 2000; Klimesch,
1999; Sirota et al., 2008).
Any pair of spectral properties (frequency, amplitude, phase) for a given signal
can theoretically exhibit coupling behavior (Hyafil, Giraud, Fontolan, & Gutkin, 2015),
but the most studied manifestations of CFC are phase-frequency, phase-phase (aka
n:m phase synchronization), phase-amplitude, and amplitude-amplitude coupling
(Hyafil, Giraud, Fontolan, & Gutkin, 2015; Jensen, & Colgin, 2007). Only phaseamplitude coupling (PAC) will be discussed further here, as mounting evidence
suggests that theta-gamma PAC is important to memory processes (Axmacher et al.,
2010; Friese et al., 2013; Fuentemilla, Penny, Cashdollar, Bunzeck, & Düzel, 2010;
Heusser, Poeppel, Ezzyat, & Davachi, 2016; Lega, Burke, Jacobs, & Kahana, 2014).
PAC – also called nested oscillation – represents the coupling of the phase of low
frequency activity to the amplitude of faster activity (Heusser, Poeppel, Ezzyat, &
Davachi, 2016), and has been proposed as a mechanism to explain phenomena such
as working memory capacity (Lisman & Idiart, 1995) and the number of visual items that
can be processed within a single perceptual ‘snapshot’ (VanRullen & Koch, 2003). In
the case of working memory capacity, Miller’s (1956) famous “magical number seven
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plus or minus two” corresponds to the approximately seven gamma cycles that can nest
within a single cycle of theta.
Generally, PAC posits that individual items are represented by neural cell
assemblies operating in high (i.e. gamma) frequency bands, and that these individual
items – carried as gamma cycles – are ordered along the phase of an underlying slower
rhythm (Lisman & Idiart, 1995). PAC has been proposed as a means of encoding the
temporal order of episodic memories (Heusser, Poeppel, Ezzyat, & Davachi, 2016) and
as a mechanism involved in learning specific associations between items by grouping
them together in a compressed time window (Fell & Axmacher, 2011; Jensen, Idiart, &
Lisman, 1996). Memory formation by grouping disparate features together via temporal
association fits well with the temporal correlation hypothesis, which holds that the
simultaneous firing of neurons indicates that they code features of the same object
(Singer & Gray, 1995; Von Der Malsburg & Schneider, 1986).
Measuring CFC is a recently developed and rapidly burgeoning method of
indexing brain functionality that has yet to be widely investigated in the context of
clinical memory deficits as seen in MCI and AD: As such, no specific hypothesis is
adopted here regarding differential theta-gamma coupling strength between these two
populations. In line with the bulk of previous research, event-related power in both theta
and gamma bands is expected to exhibit less increase over baseline in AD relative to
MCI cases, with the AD group also expected to show diminished ITPC. Regarding
expected power changes from baseline: Tonic theta frequency power, as previously
discussed, is characteristically elevated in AD, which should correspond to a small or
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even negative event-related power change – relative to this elevated baseline – in AD
individuals relative to MCI individuals, if cognitive functions (especially memory
performance) indexed by the oddball paradigm are significantly reduced in the former
population. Despite the dearth of consistent empirical evidence demonstrating reduced
gamma band frequency power in AD and/or MCI, more pronounced overall slowing of
the EEG in AD combined with the generally accepted positive association between
gamma band power and memory performance suggests that gamma band power
should be anticipated to be lower in AD relative to MCI. ITPC, as an index of the
consistency of signal phase over trials within each diagnostic condition, can be taken to
reflect the uniformity of the timing of neural activity in response to incoming stimuli
(Sauseng & Klimesch, 2008). As such, it is expected that individuals with AD will show
reduced ITPC due both to attention deficits related to damaged cholinergic basal
forebrain areas as well as to generally reduced neural network connectivity and
functionality due to widespread synaptic loss and neuronal atrophy associated with
advancing AD pathology.
Method
Participants
Data were obtained from 60 older adults recruited from an outpatient memory
clinic. Participants were patients diagnosed with either aMCI (n = 29; Mage=73.0;
SDage=9.32) or probable AD (n = 31; Mage=78.29; SDage=8.28) according to revised NIAAA criteria (McKhann et al., 2011) pre-screened for negative history of other
neurological conditions (e.g. stroke, seizure disorder, traumatic brain injury). All
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participants received financial compensation for participation. Twelve participants (nMCI =
1, nAD = 11) were being treated with cholinesterase inhibitors (donepezil) at the time of
participation, two participants with AD had also been prescribed the NMDA receptor
antagonist memantine, and medication information was unavailable for 30 participants
(nMCI = 16, nAD = 14). Four participants with incomplete data resulting from technical
issues during data collection (n = 2) or requests to discontinue (n = 2) were excluded
from analyses. Assent was obtained from each participant and written informed
consent was obtained from a surrogate present at the time of participation, in
compliance with institutional protocols.
Materials
All participants performed cognitive, hearing, and vision assessments prior to
having their EEG data recorded while performing a computerized set of tasks designed
to activate selected neurological processes.
Cognitive Assessment. The Montreal Cognitive Assessment (MoCA), a brief,
comprehensive screening tool designed to be sensitive to early changes across major
cognitive domains (Nasreddine et al., 2005), was used to assess global cognitive
function. The MoCA is a 30-point screening tool with a clinical cutoff of 26 (scores less
than 26 indicate possible cognitive impairment). Seven sub-scores can be calculated for
items in visuospatial/executive, naming, attention, language/fluency, abstraction,
delayed recall, and orientation domains.
Vision Assessment. Visual acuity at the time of testing was calculated with a
standard Snellen chart.
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Hearing Assessment. The Hearing Handicap Inventory for the ElderlyScreening Version (HHIE-S; Ventry & Weinstein, 1982), a 40-point, 10-item
questionnaire, was given to assess individual perception of the social and emotional
effects of hearing loss. Scores of 0-8 denote no self-perceived handicap; Scores of 8-22
suggest mild-moderate handicap; Scores of 24-40 indicate significant handicap.
Neurometric Assessment.

Responses to visual oddball stimuli analyzed

throughout this paper were collected as part of a brief neurometric battery (BNB;
Kieffaber, Okhravi, Hershaw, & Cunningham, 2016) in which a series of nonoverlapping auditory and visual stimuli are presented over a 2600 ms interval. This
electrophysiological battery was programmed in MATLAB (R2012b; The Mathworks,
Inc., Natick, MA). Task instructions were presented on-screen and reviewed verbally
with the participant to ensure comfort with the requirements of the task. Three practice
rounds, each consisting of 10 trials, were provided. The first practice round consisted
solely of target stimuli; additional visual stimuli were added in the second practice
round; and auditory stimuli were incorporated in the final practice sequence. The battery
contained 400 total trials with a self-timed break provided after 200 trials.
Visual stimuli. Visual stimuli were presented on a computer monitor against a
gray background. In each trial, a number (‘1’ or ‘2’) and letter (‘X’ or ‘O’) were presented
laterally with respect to a continuously-displayed central fixation, subtending a visual
angle of 14.25°. The design was counterbalanced such that 50% of participants were
directed to respond to letters, and 50% were directed to respond to numbers.
Participants were instructed to attend to either numbers or letters (e.g. “Press the left
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control button if you see a ‘1’ and the right control button if you see a ‘2’”), with
responses entered on a standard QWERTY keyboard. For each participant, stimuli in
the target set were randomly assigned to be either standard or deviant (oddball).
Oddball targets were presented on 15% of trials, enabling measurement of an oddball
ERSP. Visual stimuli were presented for a fixed duration of 250 ms, with variable onset
in the interval 200-1050 ms from the start of a trial.
Procedure
Participants were invited to take part in the study following a scheduled visit to
their regular outpatient memory clinic. After participants and surrogates provided
assent and informed consent, respectively, participants were administered the MoCA,
hearing, and vision assessments. Following these assessments, participants were fitted
with an EEG cap and completed the neurometric battery. From consent to completion,
the procedure lasted approximately one hour.
EEG recording and analysis. Continuous electrophysiological data were
recorded using a high-impedance DBPA-1 Sensorium bio-amplifier (Sensorium, Inc.,
Charlotte, VT) with an analog high-pass filter of 0.01 Hz. Recordings were acquired at a
rate of 2000 samples per second from an extended 10/20 cap system with 21 Ag-AgCl
sintered electrodes while participants were seated facing a computer monitor in an
unshielded, unlit room. The ground electrode was positioned on the center of the
forehead and the reference was affixed to the right side of the nose. Impedances were
adjusted to be within 0-20 kΩ prior to each recording session.
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EEG data were processed offline in MATLAB R2016a (The Mathworks, Inc.,
Natick, MA) using the EEGLAB (Delorme & Makeig, 2004) toolbox. Raw data were
resampled to 1000 Hz and an initial IIR Butterworth 0.1-100 Hz band-pass filter was
applied (half-amplitude cutoff of 6 dB, roll-off of 12 dB/octave). Data were visually
inspected, and channels containing extreme artifact were interpolated. A maximum of
five channels were interpolated for any participant (M = 1.06, SD = 1.62). Ocular
artifacts were identified and removed using the runica EEGlab toolbox function, which
utilizes an infomax independent component analysis (ICA) algorithm (Delorme &
Makeig, 2004; Jung et al., 2000). After pre-processing to remove extreme artifact, each
channel of EEG data was decomposed into the five classically defined EEG sub-bands:
delta (0.5–4 Hz), theta (4–7 Hz), alpha (8–12 Hz), beta (13–30 Hz) and gamma (30–40
Hz).
Frequency, time-frequency, and ITPC measures. Continuous EEG was
decomposed using the EEGlab toolbox functions spectopo (frequency power) and
newtimef (time-frequency power and ITPC). Both functions measure the power and/or
phase consistency of the underlying signal by means of complex Morlet wavelet
transformation, which provides a good compromise between time and frequency
resolution (Sinkkonen, Tiitinen, & Näätänen, 1995). Analyses utilized a 200 ms prestimulus baseline period along with all newtimef default wavelet parameters.
Phase-amplitude coupling measure. Strength of theta-gamma coupling was
measured with the modulation index (MI; Canolty et al., 2006) as implemented in the
freely available MATLAB code developed by Onslow and colleagues (2011). In this
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particular implementation, instantaneous amplitude and phase are first calculated over
the range of frequencies contained in the signal by filtering the continuous EEG data via
convolution with complex Morlet wavelets, with instantaneous amplitude given by the
absolute vale of the analytic signal and instantaneous phase given by the phase angle
of the complex-valued signal (Onslow, Bogacz, & Jones, 2011). The MI measure
generates a joint probability density function in the complex plane arising from the
composite of the envelope values of the amplitude of the higher frequency signal and
the instantaneous phase of the lower frequency signal, with non-zero MI values
indicating that particular amplitude and phase values tend to co-occur in time (Onslow,
Bogacz, & Jones, 2011).
Statistical Analysis
Participant-level characteristics (see Table 1) were tested for group differences
with independent-samples t-tests. ERSP, ITPC, and PAC measures at electrode
locations Fz, Cz, Pz, and Oz were compared. ERSP and event-related ITPC values for
standard stimuli were first subtracted from values of oddball trials to derive a measure of
the oddball effect for the AD and MCI groups individually (see Figures 2 & 3). This level
of subtraction provides a measure of the cognitive processes involved in detecting and
selecting target stimuli removed from the sensory related spectral activity involved in
simply viewing standard stimuli. Group level oddball effects were then subject to
another round of subtraction (MCI – AD; see Figures 4 & 5) in order to compare the
differences in the spectral values associated with the cognitive processes involved in
the oddball paradigm between the two groups at each time point in the analysis. MI
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values of PAC between theta (4-8 Hz) and a range of gamma frequencies spanning
from 33-83 Hz in steps of 5 Hz were compared between the two groups. As all ERSP,
ITPC, and PAC analyses were performed at each electrode location across multiple
frequency bands, with ERSP and ITPC analyses additionally performed at each time
point, p-values (when initially significant) were adjusted for multiple comparisons using
the false discovery rate (FDR) method of Benjamini and Hochberg (1995).
Results
For ERSP and ITPC comparisons, timepoints after approximately 300 ms (taken
to reflect cognitive, rather than sensory processing) were examined.
Comparing differences in oddball effect elicited ERSP between groups (see
Figure 4) did not indicate significant differences within the gamma or theta bands of
interest at any electrode location. Highly similar oddball event related frequency band
power responses are also seen at all electrode locations and all frequency bands when
averaging activity over time (see Figure 1).
Comparing differences in oddball effect elicited ITPC between groups (see
Figure 5) revealed a consistent pattern at all central electrode locations of significant
differences within the gamma band focused around 30-40 Hz within a time range of
300-500 ms post-stimulus. Somewhat counterintuitively, ITPC values for AD were
higher than those for MCI (see Discussion section).
Comparing differences in oddball effect elicited PAC between groups did not
indicate significantly different theta-gamma coupling at any electrode location. PAC
values did not correlate strongly with either MoCA scores or hippocampal occupancy
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measures (see Table 2) commonly used in the diagnosis of AD. Ignoring diagnostic
group, standard and oddball visual stimuli did not elicit significantly differing PAC MI
values (t(59) = -1.80 – 1.76, p = 0.08 – 0.97, ns; see Discussion section). There was
also no interaction between diagnostic condition and stimulus type (t(1)=0.54, p=0.46,
ns).
Discussion
Overall, ERSP and PAC measures failed to show distinctive differences between
AD and MCI groups, while ITPC exhibited significant differences within the time range of
interest in an unexpected direction (higher in AD). The pattern of results observed in
this study is consistent with oft-conflicting results of EEG-derived indices of AD and/or
MCI reported in the extant literature and, perhaps, reflective of highly variable
underlying patterns of neural pathology presented by such clinically heterogeneous
diseases.
Visual inspection of oddball effect ERSP plots (see Figure 4) shows a consistent,
rhythmic pattern of gamma power increases in both patient groups beginning at ~100
ms post-stimulus and continuing throughout the remainder of these epochs. One can
imagine a sinusoidal wave at theta frequency snaking through these clusters of high
gamma activity, suggesting that activity in the ~30 – 50 Hz range is being modulated at
theta frequency during oddball trials, even if this modulation does not differ to a
statistically significant extent between diagnostic categories. These islands of high
gamma power occur much more regularly in MCI patients, with the clusters of gamma
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also taking place at higher frequency and are confined to a tighter frequency range for
MCI as compared to AD individuals (~ 45-50 Hz for MCI vs. ~30-40 Hz for AD).
Higher gamma ITPC values observed in AD relative to MCI cases could be
explained by a non-linear, U-shaped pattern of disease-related change in this metric as
individuals advance from MCI to AD. ITPC increases at 400ms between 30-40 Hz (see
Figure 5) seen at all three electrode locations could also be indicative of additional,
compensatory neural activation triggered within the brains of AD patients in order to
attend to and recognize oddball stimuli. A third possibility is that a much higher
proportion of AD participants were taking prescription AChEl (see Limitations section)
and the observed higher gamma ITPC in this group could be a pure medication effect.
As it has been observed (Başar, 2013) that medication status can drastically alter the
electrical signals observed and thus the overall picture of cognitive functioning and how
it relates to disease pathology in any study investigating cognitive impairment utilizing
frequency domain analysis, results observed here must be interpreted with caution.
While PAC values did not reliably differentiate between the AD and MCI groups
of our sample, the fact that PAC values for standard and oddball visual stimuli did not
differ significantly even within subjects suggests that other paradigms (or a different
implementation of the oddball paradigm) may provide a better measure of cognitive
event related PAC. Also, there are many quantification methods in addition to the MI
used to measure PAC here (Canolty et al., 2006; Onslow, Bogacz, & Jones, 2011), and
perhaps future investigations will find that a different calculation method possesses
more desirable statistical properties for applications such as this.
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Conclusions
To advance the development of treatment interventions to prevent, or at least to
delay, the onset of the debilitating behavioral and cognitive impairments brought on by
AD, practical and cost effective tools that can help to both identify at-risk individuals at
the earliest possible juncture and to quantifiably assess disease progression are
urgently needed. Criteria for an ideal biomarker of AD developed by the Ronald and
Nancy Reagan Research Institute of the Alzheimer's Association and the National
Institute of Aging Working Group (Davies et al., 1998) state that such a marker should
be: reliable, non-invasive, simple to perform, precise, inexpensive, and able to detect a
fundamental feature of AD neuropathology. The ability to monitor brain activity with the
millisecond temporal resolution required to gauge neuronal synchrony and measure the
integrity of synaptic transmission, along with cost and ease of use advantages relative
to other neuroimaging methods and molecular chemical assays, all recommend
electroencephalograph (EEG) recordings as an informative and practical diagnostic tool
in the battle against AD.
While the idea of a rhythm disease is not new (Buzsáki, 2011; John, 1977),
developing consensus that oscillatory activity detectable via EEG plays a functional role
in neuronal communication has only recently led some to consider AD within this
category (Nimmrich, Draguhn, & Axmacher, 2015). Viewing a neurological and
psychiatric disorder such as AD as a dysrhythmia or oscillopathy provides a fresh
perspective that might yield new insights into the condition (Palop, Chin, & Mucke,
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2006) at a time when the prevailing amyloid cascade hypothesis appears increasingly
untenable (Herrup, 2015).
This paper briefly summarized previous work in both clinical and basic research
domains pertaining to memory related ERSP, ITPC, and CFC activity in/between the
theta and gamma frequency bands. Results from the visual oddball task presented
here suggest that gamma band ITPC exhibits significant differences between AD and
MCI groups within a time window of ~300-500 ms, indicating that this measure merits
further investigative attention in the context of discriminating between cases of AD and
MCI.
Limitations
Medication information was only available for half of our sample population,
precluding comparisons between medicated and de novo conditions. While effects of
AChEI upon individual frequency band power and phase locking have been well
documented, little is known as to how this medication may impact interactions between
frequency bands such as CFC. Comparing MI values of PAC for the portion of our
sample with medication information showed a non-significant between group difference.
This study included no dedicated control group, preventing direct comparison
between healthy and pathological groups using the measures derived herein. While the
main thrust of this research was to uncover EEG derived indicators that may be useful
in distinguishing AD from MCI, including an age-matched control group would provide a
better picture of the overall spectrum of functional impairment changes in these
measures may represent.
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Some authors (e.g. Donner & Siegel, 2011; Klimesch, 1999) have recommended
eschewing classical frequency band definitions, advocating that data-driven frequency
grouping done at the individual participant level better capture oscillatory dynamics that
may take place over multiple or be limited to only a portion of traditional frequency
ranges. In the opinion of this author, such an approach would make for highly circular
inferences while severely limiting both the generalizability of findings and the ability to
compare results to those of previous studies: Thus, classic frequency bands were
examined.
Commonly implemented calculations of CFC, including the measure of PAC used
herein, yield poor temporal resolution (Tort, Komorowski, Eichenbaum, & Kopell, 2010),
negating the main advantage EEG/MEG holds over other neuroimaging methods.
Additionally, longer trial epochs than were used in the current study would have proven
beneficial in resolving low-frequency signal characteristics.
Directions for Future Studies
Event-related PAC (ERPAC; Voytek, D’Esposito, Crone, & Knight, 2013) analysis
would help to address the issue of poor temporal resolution and could yield important
insights into the time course of PAC and how this metric may differ between AD and
MCI populations.
Source localization of all signals of interest would help to better pinpoint and
differentiate the contributions of specific neuronal assemblies to the observed EEG
indicators and could facilitate better targeted treatment interventions. Additionally,
performing source localization of theta and gamma activity separately as well as for the
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coupled theta-gamma PAC value could indicate when and where these signals are most
prevalent individually while performing oddball-type visual discrimination tasks as well
as where they most strongly interact.
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Table 1
Participant Characteristics by Diagnostic Category
aMCI (n = 29)

AD (n = 31)

M (SD)

M (SD)

t(df)

Age (years)

73.00 (9.32)

78.29 (8.28)

-2.32(58)*

Education (years)

15.24 (2.28)

13.89 (2.30)

2.22(55)*

Gender (n female)

17

22

MoCA (__/30)

21.34 (2.41)

16.74 (4.20)

5.16(58)**

Vision (20/__)

30.69 (11.24)

31.00 (9.51)

-0.12(57)

Hippocampal Volume (cm3)

6.67 (1.11)

6.08 (0.98)

1.84(41)

Inferior Lateral Ventricle Volume (cm3)

2.79 (1.33)

3.62 (1.69)

-1.79(41)

Lateral Ventricle Volume (cm3)

38.99 (15.90)

52.94 (30.94)

-1.90(41)

Hippocampal Occupancy score

0.71 (0.11)

0.64 (0.11)

2.12(42)*

Notes. * p < .05; **p < .01. Hippocampal occupancy score is calculated as the ratio of
hippocampal volume to the sum of hippocampal volume and inferior lateral ventricle
volume.
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Table 2
Correlations Among Key Participant Variables and PAC Values

Variables
HipOc.
Age
MoCA

HipOc

Age

MoCA

Educ.

Vision

PACfz

PACcz

PACoz

-.49**

.28

.22

.03

-.05

.02

-.11

-.31*

-.32*

.25

-.04

-.01

.20

-.05

.12

.07

.09

-.02

.35**

.41**

.16

-.01

-.02

.07

.80**

.42**

.29*

Educ.
Vision
PACfz
PACcz

.53**

PACoz

Notes. * p < .05; ** p < .01. PAC values at locations Fz, Cz, and Oz were log
transformed prior to correlation. HipOc. = hippocampal occupancy score. Educ. = years
of education.
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Figure 1. Event related frequency band power by diagnosis for oddball trials at
hemispheric midline electrode locations, ordered (from the front of the head to the back)
Fz, Cz, Pz, Oz. All between-group differences statistically non-significant (p > 0.05).
Bars indicate the standard error of the mean.
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X axis = Time in milliseconds
Y axis = Frequency in hertz
Z axis = dB normalized power change from baseline

Figure 2. Deriving oddball-effect (Target – Standard visual stimuli) ERSP plots for AD
participants.
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X axis = Time in milliseconds
Y axis = Frequency in hertz
Z axis = dB normalized power change from baseline

Figure 3. Deriving oddball-effect (Target – Standard visual stimuli) ERSP plots for MCI
participants.
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X axis = Time in milliseconds
Y axis = Frequency in hertz
Z axis = dB normalized power change from baseline or statistical significance

Figure 4. Comparing oddball-effect ERSP plots for MCI and AD participants. Significant
differences shown in green indicate FDR-adjusted p <.05.
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X axis = Time in milliseconds
Y axis = Frequency in hertz
Z axis = Phase Locking Value (range 0-1) or statistical significance

Figure 5. Comparing oddball-effect ITPC plots for MCI and AD participants. Significant
differences shown in green indicate FDR-adjusted p <.05.
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